People: Cempra Inc (CEMP.W)

CEMP.W on CBOE When Trading NASDAQ Global Select Market

9.01USD
14 Apr 2014
Price Change (% chg)

$-1.67 (-15.64%)
Prev Close
$10.68
Open
$9.51
Day's High
$9.51
Day's Low
$8.84
Volume
404
Avg. Vol
706
52-wk High
$15.30
52-wk Low
$6.17

Search Stocks

Gill, David 

Brief Biography

Mr. David Gill is Independent Director of Cempra, Inc. He joined INC Research, a clinical research organization, in February 2011 as Chief Financial Officer after having served as a board member and Audit Committee chairman from 2007 to 2010. He was previously the Chief Financial Officer of TransEnterix, a private medical device company from March 2009 to February 2011. Mr. Gill was Chief Financial Officer and Treasurer of NxStage Medical, Inc, a publicly-traded dialysis equipment company, from July 2005 to November 2006 at which time he retired to pursue several board of director opportunities, including LeMaitre Vascular (LMAT) and Isotis Biologics (ISOT).

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Search Stocks